{"id":4410,"date":"2026-03-27T07:30:00","date_gmt":"2026-03-27T06:30:00","guid":{"rendered":"https:\/\/ibtherapeutics.com\/sv\/mfn_news\/infant-bacterial-therapeutics-ab-publicerar-arsredovisning-for-2025\/"},"modified":"2026-03-27T07:30:00","modified_gmt":"2026-03-27T06:30:00","slug":"infant-bacterial-therapeutics-ab-publicerar-arsredovisning-for-2025","status":"publish","type":"mfn_news","link":"https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/infant-bacterial-therapeutics-ab-publicerar-arsredovisning-for-2025\/","title":{"rendered":"Infant Bacterial Therapeutics AB publicerar \u00c5rsredovisning f\u00f6r 2025"},"content":{"rendered":"<div class=\"mfn-body\">\n<p><strong>\u00c5rsredovisningen inklusive Bolagsstyrningsrapport f\u00f6r 2025 finns tillg\u00e4nglig p\u00e5 IBT:s hemsida, www.ibtherapeutics.com under avsnitt &#034;Investerare &amp; Media &#8211; Finansiella rapporter&#034;.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-regulatory mfn-regulatory-vpml\">\n<p><em>Denna information \u00e4r s\u00e5dan information som Infant Bacterial Therapeutics \u00e4r skyldigt att offentligg\u00f6ra enligt lagen om v\u00e4rdepappersmarknaden. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersoners f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 2026-03-27 07:30 CET.<\/em><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<hr \/>\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><br \/><a class=\"mfn-primary\" href=\"https:\/\/storage.mfn.se\/449abd44-afaa-46ad-995c-08b57376acb7\/ibt-ar-2025-swe.pdf\" rel=\"noopener\" target=\"_blank\">IBT \u00c5R 2025 SWE<\/a><br \/><a href=\"https:\/\/storage.mfn.se\/b6417099-9b07-4b38-9632-6a3dc6cba281\/ibt-ar-2025-swe.xhtml\" rel=\"noopener\" target=\"_blank\">IBT \u00c5R 2025 SWE<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/449abd44-afaa-46ad-995c-08b57376acb7\/ibt-ar-2025-swe.pdf\"><span class=\"mfn-attachment-icon\"><img alt=\"Infant Bacterial Therapeutics AB publicerar \u00c5rsredovisning f\u00f6r 2025\" src=\"https:\/\/storage.mfn.se\/449abd44-afaa-46ad-995c-08b57376acb7\/ibt-ar-2025-swe.pdf?type=jpg\"><\/span>IBT \u00c5R 2025 SWE<\/a><\/div><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/b6417099-9b07-4b38-9632-6a3dc6cba281\/ibt-ar-2025-swe.xhtml\"><span class=\"mfn-attachment-icon\"><span class=\"dash dashicons dashicons-media-default\"><\/span><\/span>IBT \u00c5R 2025 SWE<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>\u00c5rsredovisningen inklusive Bolagsstyrningsrapport f\u00f6r 2025 finns tillg\u00e4nglig p\u00e5 IBT:s hemsida, www.ibtherapeutics.com under avsnitt &#034;Investerare &amp; Media &#8211; Finansiella rapporter&#034;. Denna information \u00e4r s\u00e5dan information som Infant Bacterial Therapeutics \u00e4r skyldigt att offentligg\u00f6ra enligt lagen om v\u00e4rdepappersmarknaden. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersoners f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 2026-03-27 07:30 CET. Bifogade filerIBT \u00c5R 2025 SWEIBT \u00c5R 2025 [&hellip;]<\/p>\n","protected":false},"template":"","_links":{"self":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/mfn_news\/4410"}],"collection":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=4410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}